Biomarkers-based personalized follow-up in chronic heart failure improves patient's outcomes and reduces care associate cost.
Antonio Leon-JustelJose I Morgado Garcia-PolaviejaAna Isabel Alvarez-RiosFrancisco Jose Caro FernandezPedro Agustin Pajaro MerinoElena Galvez RiosIgnacio Vazquez-RicoJose Francisco Diaz FernandezPublished in: Health and quality of life outcomes (2021)
A personalized follow-up of HF patients led to important outcome benefits and resulted in cost savings, mainly due to the reduction of patient hospitalization readmissions and a significant reduction of care-associated costs, suggesting that greater attention should be given to this high-risk cohort to minimize the risk of hospitalization readmissions.